Trending

Sarcopenia Treatment Market Scope and overview, Market Scope and overview, Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2030

The global sarcopenia treatment market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2030, and the market value anticipates to reach USD 4700 million by 2030.

The global sarcopenia treatment market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2030, and the market value anticipates to reach USD 4700 million by 2030.

Sarcopenia Treatment Market Status, Trends and COVID-19 Impact Report 2021, Covid 19 Outbreak Impact research report added by Quadintel, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider  Sarcopenia Treatment Market , and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Digital Evidence Management market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get complete Report (Including Full TOC, 100+ Tables & Figures, and Chart). – In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis & Situation by Region

Request Sample Report for Sarcopenia Treatment Market : –https://www.quadintel.com/request-sample/sarcopenia-treatment-market/QI040

A condition known as sarcopenia occurs when skeletal muscle mass or flesh decreases with aging. Reduced muscle mass, relative weakness, a lack of stamina, and problems climbing stairs are some of the symptoms of sarcopenia. In addition, to exercise level and co-morbidities, there are other factors affecting muscle loss. Sarcopenia can impair quality of life and lead to disability. The aging process causes muscles to lose strength and muscle mass.

Malnutrition is a result of low consumption of micronutrient-rich foods in developing and low-income countries. It results from malnutrition or vitamin D and vitamin B12 deficiency. Vegetarians and the elderly are more at risk for this condition. Therefore, sarcopenia has no recognized treatment; however, proper nutrition and dietary supplements can help. During periods of muscle inactivity, diet prevents accelerated muscle loss and keeps energy levels up. A few of the most effective supplements for treating sarcopenia are proteins, amino acids, omega-3 fatty acids, creatine, vitamin D, and vitamin B12.

Factors Affecting

Factors driving the global sarcopenia treatment market include an aging population and the increasing acceptance of vitamins and dietary supplements. The World Health Organization predicts that by 2050, there will be 2 billion people aged 60 and older in the world, up from 900 million in 2015. Furthermore, a rise in sarcopenia cases will drive the growth of treatment products for the condition.
Sarcopenia treatment market growth will also benefit from an increase in R&D activities.

During the forecast period, high protein supplement prices and a lack of awareness will hinder the market growth.
As malnutrition and vitamin deficiency rise in developing countries and healthcare spending rises per capita, sarcopenia treatment supplements will likely become more in demand.
The increase in malnutrition cases resulting from poor nutrition will provide additional growth opportunities for the sarcopenia treatment market during the forecast period.
Despite these obstacles, protein supplement prices could increase, and sarcopenia treatment drugs will become more difficult to acquire.

Impact Analysis of COVID-19

The COVID-19 study may boost sarcopenia treatment market growth. COVID-19 infection causes a systematic inflammation that leads to skeletal muscle death in patients with sarcopenia. In addition, older people who suffered social isolation during the COVID-19 pandemic suffered protein deficiencies and reduced physical activity, which lead to accelerated muscle weakness and dysfunction. Those with COVID-19 are also likely to experience secondary sarcopenia for two or three weeks after diagnosis. The result was an increase in the demand for protein supplements that promote muscle growth and increase muscle strength. A secondary recommendation should be to have physically isolated individuals do daily exercises such as ViviFrail graded exercise, the primary treatment for sarcopenia. COVID-19 has therefore grown positively as a result of such factors.

Request To Download Sample of This Strategic Report : –https://www.quadintel.com/request-sample/sarcopenia-treatment-market/QI040

Regional Overview

The Asia-Pacific region accounted for the largest share, continuing to retain its dominance through 2030 due to high R&D spending, the presence of leading players and their products, and well-established healthcare infrastructure.

Prominent Players

The prominent players profiled in the global sarcopenia treatment market are:

Abbott Laboratories, Inc. (U.S.)
American Way (Amway) Corporation (U.S.)
Bayer AG (Germany)
GlaxoSmithKline plc. (U.K.)
Nestle S.A. (Europe)
Pfizer, Inc. (U.S.)
Novartis AG (Europe)
Sanofi, Inc. (France)
Zydus Cadila, Ltd (India)
F-Hoffmann La-Roche (Europe)
Other Prominent Players
Scope of the Report

The global sarcopenia market segmentation focuses on Treatment, Route of Administration, Distribution Channel, and Region.

Segmentation based on Treatment

Protein Supplements
Vitamin B12 Supplements
Vitamin D & Calcium Supplements
Others
Segmentation based on Route of Administration

Oral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Parenteral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Enteral
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Segmentation based on Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Segmentation based on Region

Get a Sample PDF copy of the report : – https://www.quadintel.com/request-sample/sarcopenia-treatment-market/QI040

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Access Full Report, here : –https://www.quadintel.com/request-sample/sarcopenia-treatment-market/QI040

Key Questions Answered in the Market Report

• How did the COVID-19 pandemic impact the adoption of by various pharmaceutical and life sciences companies?
• What is the outlook for the impact market during the forecast period 2021-2030?
• What are the key trends influencing the impact market? How will they influence the market in short-, mid-, and long-term duration?
• What is the end user perception toward?
• How is the patent landscape for pharmaceutical quality? Which country/cluster witnessed the highest patent filing from January 2014-June 2021?
• What are the key factors impacting the impact market? What will be their impact in short-, mid-, and long-term duration?
• What are the key opportunities areas in the impact market? What is their potential in short-, mid-, and long-term duration?
• What are the key strategies adopted by companies in the impact market?
• What are the key application areas of the impact market? Which application is expected to hold the highest growth potential during the forecast period 2021-2030?
• What is the preferred deployment model for the impact? What is the growth potential of various deployment models present in the market?
• Who are the key end users of pharmaceutical quality? What is their respective share in the impact market?
• Which regional market is expected to hold the highest growth potential in the impact market during the forecast period 2021-2030?
• Which are the key players in the impact market?

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Quadintel:
Email: sales@quadintel.com
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.quadintel.com/

Related Articles

Back to top button